跳轉至內容
Merck

LC/MS (TOF) Analysis of Dermorphin on Ascentis® Express F5

LC/MS (TOF) Analysis of Dermorphin on Ascentis® Express F5 application for HPLC

材料

分析柱

產品號碼
描述
訂價

Ascentis® Express F5, 2.7 μm HPLC 色谱柱

2.7 μm particle size, L × I.D. 10 cm × 2.1 mm

CONDITIONS

column

Ascentis Express F5, 10 cm x 2.1 mm I.D., 2.7 μm particles (53569-U)

mobile phase

2 mM ammonium formate (90:10 acetonitrile:water) adjusted to pH 4.5 with formic acid

flow rate

0.4 mL/min

column temp.

35 °C

detector

ESI(+), TIC 100 – 1000 m/z; APCI (+), XIC m/z = 150.1, 203.7, 378.2

injection

1 μL

sample

10 μg/mL in 75:25 acetonitrile:water

描述

分析報告

Dermorphin is a heptapeptide derived from frogs. It is a painkiller and used illicitly in racehorses so they continue to run through the pain. A rapid analysis of dermorphin standard is shown here on an Ascentis Express F5 column. The HILIC mode separation provided the necessary retention and MS-compatibility, while the pentafluorophenyl (F5) phase chemistry elimated the chelating interactions that are problematic on bare silica.

法律資訊

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany